scholarly journals Stem Cell-Derived Pancreatic Progenitor Cells Have Now Been Transplanted into Patients: Report from IPITA 2018

2018 ◽  
Vol 18 (7) ◽  
pp. 1581-1582 ◽  
Author(s):  
Lara C. Pullen
2015 ◽  
Vol 5 (6) ◽  
pp. 1081-1096 ◽  
Author(s):  
Jennifer E. Bruin ◽  
Ali Asadi ◽  
Jessica K. Fox ◽  
Suheda Erener ◽  
Alireza Rezania ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Zongzhe Jiang ◽  
Jingjing Tian ◽  
Wenjian Zhang ◽  
Hao Yan ◽  
Liping Liu ◽  
...  

Our colleagues have reported previously that human pancreatic progenitor cells can readily differentiate into insulin-containing cells. Particularly, transplantation of these cell clusters upon in vitro induction for 3-4 w partially restores hyperglycemia in diabetic nude mice. In this study, we used human fetal pancreatic progenitor cells to identify the forkhead protein FoxO1 as the key regulator for cell differentiation. Thus, induction of human fetal pancreatic progenitor cells for 1 week led to increase of the pancreatic β cell markers such as Ngn3, but decrease of stem cell markers including Oct4, Nanog, and CK19. Of note, FoxO1 knockdown or FoxO1 inhibitor significantly upregulated Ngn3 and insulin as well as the markers such as Glut2, Kir6.2, SUR1, and VDCC, which are designated for mature β cells. On the contrary, overexpression of FoxO1 suppressed the induction and reduced expression of these β cell markers. Taken together, these results suggest that FoxO1 may act as a repressor to inhibit cell differentiation in human fetal pancreatic progenitor cells.


Pancreatology ◽  
2016 ◽  
Vol 16 (4) ◽  
pp. S143
Author(s):  
Yuuki Ise ◽  
Kazuya Shimizu ◽  
Kyohei Uenoyama ◽  
Satoshi Nishiyama ◽  
Yuka Tsuchida ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document